Abstract
This report analyzes the worldwide markets for Organ And Tissue
Transplantation by Number of Procedures. The specific product segments
analyzed for the global and other markets (except the US) by Organ Type are
Heart, Kidneys, Liver, Pancreas, Lungs, and Intestine. The US market has been
specifically analyzed both by Organ & Tissue Transplantation market, and Bone
Graft Transplantation market. The report analyzes the US market for Organ &
Tissue Transplantation both by Organ Type (Heart, Kidneys, Liver, Pancreas,
and Lungs) and by Tissue Type (Cornea, Heart Valve, Skin Grafts, Vascular
Grafts, Bone Marrow, and Bone Grafts). Bone Graft Transplantation market in
the US is analyzed both by Graft Type (Autologous Graft, Allograft, and Other
Materials); and by Application Type (General Orthopedics, Spinal Fusions, and
Cranio/Maxillofacial). The report provides separate comprehensive analytics
for the US, Canada, Europe, Asia, Latin America, and Rest of World. Annual
forecasts are provided for each region for the period of 2003 through 2012.
The report profiles 77 companies including many key and niche players
worldwide such as Abiomed Inc., Arbios Systems, Inc., CryoLife, Inc.,
Exactech, Inc., Fresenius Medical Care AG & Co. KGaA, Forticell Bioscience,
Inc., Gambro AB, Genzyme Corporation, Jarvik Heart, Inc., LifeCell
Corporation, Medtronic, Inc., MicroMed Cardiovascular, Inc., Organogenesis,
Inc., SynCardia Systems, Terumo Corporation, Thoratec Corporation, Ventracor
Limited, and WorldHeart Corporation. Market data and analytics are derived
from primary and secondary research. Company profiles are mostly extracted
from URL research and reported select online sources.
| 
View Cart
